Illustration by David Goodsell.
Engineered T cell recognizing and
attacking a leukemia cell.
More information at
pdb101.rcsb.org/motm/214

Co-organized by:
Institute for Quantitative Biomedicine (IQB)
Cancer Institute of New Jersey (CINJ)

Tuesday, October 29 | 1:00 PM - 6:00 PM
Proteomics Building, Room 120
Busch Campus

Program | Download PDF

Co-Chairs: Stephen K. Burley and Edmund C. Lattime

1:00–1:15 pm

IQB Welcome
Stephen K. Burley, M.D., D.Phil. - IQB, C&CB, CINJ

CINJ Welcome
Eileen White, Ph.D. – CINJ
 

1:15–1:45 pm

Immuno-oncology Paradigm/Crash Course Objectives
Edmund C. Lattime, Ph.D. – CINJ

1:45–2:15 pm

Structural Biology of the T cell Surface
Stephen K. Burley, M.D., D.Phil. – RCSB Protein Data Bank

2:15–3:00 pm

A Biologics Platform for Clonal-selective T cell Modulation
Steven C. Almo, Ph.D. – Albert Einstein College of Medicine

3:00–3:30 pm

Group Photo (outside building weather permitting)
Coffee/Tea/Networking

3:30–4:15 pm

Interaction Kinetics and Transcriptomic Responses with
CD19 CAR NK Cell Therapy in Lymphoma
Andrew M. Evens, D.O., M.Sc. – CINJ

4:15–5:00 pm

Kymriah: Past, Present, and Future
Randi E. Isaacs, M.D. – Novartis Institutes for Biomedical Research

5:00–5:10 pm

Acknowledgments/Closing Remarks
Stephen K. Burley, M.D., D.Phil. – IQB, C&CB, CINJ

5:10-6:00pmNetworking Reception

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Recordings

  1. Structural Biology of the T cell Surface - Stephen K. Burley, M.D., D.Phil. – RCSB Protein Data Ban